BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31559281)

  • 21. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature.
    Qi X; Han G
    Hepatol Int; 2012 Jun; 6(3):576-90. PubMed ID: 26201472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.
    D'Avola D; Bilbao JI; Zozaya G; Pardo F; Rotellar F; Iñarrairaegui M; Quiroga J; Sangro B; Herrero JI
    Transplant Proc; 2012 Nov; 44(9):2603-5. PubMed ID: 23146469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transjugular intrahepatic portosystemic shunt and splenectomy are more effective than endoscopic therapy for recurrent variceal bleeding in patients with idiopathic noncirrhotic portal hypertension.
    He FL; Qi RZ; Zhang YN; Zhang K; Zhu-Ge YZ; Wang M; Wang Y; Jia JD; Liu FQ
    World J Clin Cases; 2020 May; 8(10):1871-1877. PubMed ID: 32518776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis.
    Luca A; Miraglia R; Caruso S; Milazzo M; Sapere C; Maruzzelli L; Vizzini G; Tuzzolino F; Gridelli B; Bosch J
    Gut; 2011 Jun; 60(6):846-52. PubMed ID: 21357252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of influencing factors of shunt dysfunction after transjugular intrahepatic portosystemic shunt in liver cirrhosis accompanied with portal vein thrombosis].
    Li X; Wang HL; Zhou TY; Chen SQ; Nie CH; Zhang YL; Yu ZN; Zhou GH; Zhu TY; Sun JH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):742-746. PubMed ID: 33053973
    [No Abstract]   [Full Text] [Related]  

  • 26. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.
    Thornburg B; Desai K; Hickey R; Hohlastos E; Kulik L; Ganger D; Baker T; Abecassis M; Caicedo JC; Ladner D; Fryer J; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2017 Dec; 28(12):1714-1721.e2. PubMed ID: 29050854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding.
    Su AP; Zhang ZD; Tian BL; Zhu JQ
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):169-175. PubMed ID: 28381381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transjugular Intrahepatic Portosystemic Shunt:The Impact of Portal Venous Pressure Declines on Shunt Patency and Clinical Efficacy.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y; Guo T
    Acad Radiol; 2019 Feb; 26(2):188-195. PubMed ID: 29934023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis.
    Lakhoo J; Gaba RC
    Diagn Interv Imaging; 2016 Nov; 97(11):1085-1093. PubMed ID: 27481577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case-control study.
    Yao W; Liu JC; Wu YJ; Yang CT; Ju SG; Wang YL; Wang CY; Huang SJ; Bai YW; Chen Y; Li TQ; Zhou C; Xiong B
    Abdom Radiol (NY); 2022 Oct; 47(10):3615-3627. PubMed ID: 35821274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device.
    Lauermann J; Potthoff A; Mc Cavert M; Marquardt S; Vaske B; Rosenthal H; von Hahn T; Wacker F; Meyer BC; Rodt T
    Cardiovasc Intervent Radiol; 2016 Apr; 39(4):547-56. PubMed ID: 26404629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transjugular intrahepatic portosystemic shunt in patients with portal vein thrombosis].
    Streitparth F; Santosa F; Milz J; Gebauer B; Teichgräber U; Hamm B; Hidajat N
    Rofo; 2008 Oct; 180(10):899-905. PubMed ID: 19238640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis.
    Salem R; Vouche M; Baker T; Herrero JI; Caicedo JC; Fryer J; Hickey R; Habib A; Abecassis M; Koller F; Vogelzang R; Desai K; Thornburg B; Hohlastos E; Resnick S; Lewandowski RJ; Sato K; Ryu RK; Ganger D; Kulik L
    Transplantation; 2015 Nov; 99(11):2347-55. PubMed ID: 25905983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J; Smolinski SE; Liu F; Xu D; Dulaimy K; Irani Z
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.
    Luo X; Zhao M; Wang X; Jiang M; Yu J; Li X; Yang L
    PLoS One; 2019; 14(2):e0212658. PubMed ID: 30811467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technical success and outcomes in pediatric patients undergoing transjugular intrahepatic portosystemic shunt placement: a 20-year experience.
    Ghannam JS; Cline MR; Hage AN; Chick JFB; Srinivasa RN; Dasika NL; Srinivasa RN; Gemmete JJ
    Pediatr Radiol; 2019 Jan; 49(1):128-135. PubMed ID: 30291382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist's Experience.
    Buechter M; Manka P; Gerken G; Canbay A; Blomeyer S; Wetter A; Altenbernd J; Kahraman A; Theysohn JM
    Dig Dis; 2018; 36(3):218-227. PubMed ID: 29316565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.